Small caps round-up: Gresham Computing, Alliance Pharma, Young and Co's...

Gresham Computing has unveiled Australia and New Zealand Banking Group as its partner in a previously announced significant contract win. Under the deal Gresham will for a third time partner the bank, providing cash and information management solutions for corporate clients in an effort to increase visibility, control and efficiency in these areas. The bank said it believes the deal is the start of a long-term partnership for the two companies.

Alliance Pharma, a speciality pharmaceutical company, has said trading during the six months ended June 30th has been in line with management's expectations, with turnover of around £22m. The Hydromol produce continues to perform well, with growth of 28% over the first half of 2011. The firm said it is continuing to explore a number of acquisition opportunities, some of which are at a very advanced stage. The temporary suspension of the ImmuCyst product is expected to end in late 2013.

Young & Co's Brewery has said recent trading has improved significantly since the poor performance in the first seven weeks, as reported earlier in the year. Consequently managed house revenue for the first thirteen weeks was up 10.1%, and up 4.0% on a like-for-like basis. Managed house trading has benefited from a number of factors including the impact of last year's investments in new pubs, the addition of three sites transferred from tenancy, and strong trading during the Diamond Jubilee celebrations.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

The firm is anticipating a strong period of trading during the Olympics and it remains confident in its strategy, believing well-invested estate and management focus on growth should continue to drive superior like-for-like performance.

Leni Oil & Gas has completed the first five planned workovers on the Goudron Field and has confirmed that an average production potential per well of 10 barrels of oil per day (bopd) is achievable from existing wells. The programme was completed in 35 days at a cost of around $50,000. The upcoming transfer of the incremental production services contract to Goudron E&P will trigger payment of outstanding considerations to Cameron Oil and Gas and Sorgenia International, which the company is intending to finance out of the proceeds of the sale of the Spanish assets. The transfer is intended to expand the workover programme and to commence detailed planning for new infill wells.

Sphere Medical, a diagnostic product developer, has received an order for cardiopulmonary bypass monitors and microanalyser consumables for delivery in the fourth quarter of 2012 from Sorin Group. The order represents the first sale for the development and supply agreement relating to the CPB product which will be used by Sorin Group in market assessment studies which are scheduled to commence later this year. Sphere described the sale as an "important milestone" which demonstrates its ability to partner its products with global medical device companies.

NR